Byondis

Developer of precision medicines for cancers and auto-immune diseases

placeNijmegen, Gelderland, Netherlands calendar_todayFounded 2012 language byondis.com

Social engagement

Social engagement: 12.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%

Recent activity

16 Jun 2026
Event
BIO International Convention
28 May 2026
Leadership hire
Strategic Business Development and Licensing Advisor
18 May 2026
Leadership hire
Scientific Advisory Board member
Coming soon